Cargando…
Are researchers moving away from animal models as a result of poor clinical translation in the field of stroke? An analysis of opinion papers
OBJECTIVES: Despite decades of research using animals to develop pharmaceutical treatments for patients who have had a stroke, few therapeutic options exist. The vast majority of interventions successful in preclinical animal studies have turned out to have no efficacy in humans or to be harmful to...
Autores principales: | Pound, Pandora, Ram, Rebecca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749304/ https://www.ncbi.nlm.nih.gov/pubmed/35047687 http://dx.doi.org/10.1136/bmjos-2019-100041 |
Ejemplares similares
-
Can prospective systematic reviews of animal studies improve clinical translation?
por: Pound, Pandora, et al.
Publicado: (2020) -
Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail
por: Pound, Pandora, et al.
Publicado: (2018) -
Are Animal Models Needed to Discover, Develop and Test Pharmaceutical Drugs for Humans in the 21st Century?
por: Pound, Pandora
Publicado: (2020) -
Retrospective harm benefit analysis of pre-clinical animal research for six treatment interventions
por: Pound, Pandora, et al.
Publicado: (2018) -
Moving Away from Amyloid Beta to Move on in Alzheimer Research
por: Moreno-Treviño, María G., et al.
Publicado: (2015)